Susquehanna International Group, LLP Collegium Pharmaceutical, Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$31.4 - $39.07 $122,460 - $152,373	3,900 Added 20.21%	23,200 $896,000
Q2 2024 Aug 15, 2024	SELL	$31.36 - $39.99 $81,536 - $103,974	-2,600 Reduced 11.87%	19,300 $621,000
Q1 2024 May 07, 2024	BUY	$31.23 - $40.91 $683,937 - $895,928	21,900 New	21,900 $850,000
Q4 2022 Feb 14, 2023	BUY	$16.14 - $23.55 $150,102 - $219,015	9,300 New	9,300 $215,000
Q2 2022 Aug 15, 2022	BUY	$14.22 - $20.88 $71,100 - $104,400	5,000 Added 31.65%	20,800 $369,000
Q1 2022 May 16, 2022	BUY	$17.2 - $22.5 $1,720 - $2,250	100 Added 0.64%	15,800 $322,000
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $807,625 - $1.16 Million	-45,500 Reduced 74.35%	15,700 $310,000
Q1 2021 May 17, 2021	SELL	$19.25 - $26.1 $142,450 - $193,140	-7,400 Reduced 10.79%	61,200 $1.45 Million
Q4 2020 Feb 16, 2021	SELL	$17.83 - $22.29 $176,516 - $220,671	-9,900 Reduced 12.61%	68,600 $1.37 Million
Q3 2020 Nov 16, 2020	BUY	$15.78 - $20.82 $432,372 - $570,468	27,400 Added 53.62%	78,500 $1.63 Million
Q1 2020 May 15, 2020	SELL	$13.89 - $25.45 $104,175 - $190,875	-7,500 Reduced 12.8%	51,100 $834,000
Q4 2019 Feb 14, 2020	BUY	$10.7 - $22.24 $449,399 - $934,079	42,000 Added 253.01%	58,600 $1.21 Million
Q3 2019 Nov 14, 2019	SELL	$10.16 - $13.28 $92,456 - $120,848	-9,100 Reduced 35.41%	16,600 $191,000
Q1 2019 May 15, 2019	SELL	$13.58 - $18.72 $291,970 - $402,480	-21,500 Reduced 45.55%	25,700 $389,000
Q4 2018 Feb 14, 2019	SELL	$14.78 - $19.68 $540,948 - $720,288	-36,600 Reduced 43.68%	47,200 $810,000
Q3 2018 Nov 14, 2018	BUY	$14.16 - $24.3 $747,648 - $1.28 Million	52,800 Added 170.32%	83,800 $1.24 Million
Q2 2018 Aug 14, 2018	BUY	$21.79 - $28.29 $252,764 - $328,164	11,600 Added 59.79%	31,000 $739,000
Q4 2017 Feb 14, 2018	BUY	$9.3 - $19.14 $180,420 - $371,316	19,400	19,400 $358,000

Others Institutions Holding COLL

# of Institutions

255

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

Black Rock Inc. New York, NY

5.79M
Shares

$171 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

2.64M
Shares

$78 Million
1.79% of portfolio
Pacer Advisors, Inc. Malvern, PA

2.59M
Shares

$76.6 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.35M
Shares

$69.4 Million
0.0% of portfolio
Principal Financial Group Inc Des Moines, IA

1.75M
Shares

$51.6 Million
0.04% of portfolio

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.01B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account